KPV Peptide

Community reports on KPV — the anti-inflammatory tripeptide used for IBD, Crohn's disease, ulcerative colitis, and skin conditions. Anonymous accounts of protocols, routes, dosing, and outcomes.

2 anonymous reports

I have been struggling with seborrheic dermatitis in my scalp for more than 15 years, crusts, dandruff, greasy and dry hair, tried everything: zinc, ketoconazole, salicylic acid, charcoal, tea tree; you name it. Since December of last year I started "researching" with peptides: KLOW, Reta, KPV, TA-1... and next thing you know my dermatitis is gone.

#147
KPVThymosin Alpha-1Retatrutide

told everyone my skin "finally cleared up on its own." it was KPV, topical, mixed at home, on an inflammatory thing three dermatologists threw steroids at for years

#091
KPV

We're collecting more reports on this topic.

Submit yours

community guides:

Peptide Side EffectsReconstituting PeptidesInjecting Peptides

related topics:

Peptides for Gut HealthBPC-157Peptide Side Effects

Community Q&A

What is KPV peptide and what is it used for?
KPV is a tripeptide — lysine-proline-valine — derived from the C-terminal of alpha-MSH (alpha-melanocyte-stimulating hormone). Community accounts describe three dominant use cases: inflammatory bowel conditions (Crohn's disease, ulcerative colitis), skin inflammation (eczema, psoriasis, dermatitis), and general gut healing. It is most frequently framed as an anti-inflammatory compound with a localised mechanism — accounts consistently describe targeting a specific condition rather than using it systemically. The oral or suppository routes appear more often in gut-focused accounts; topical application in skin-focused accounts.
Does KPV help with IBD and gut inflammation?
Community accounts from users with IBD (Crohn's, ulcerative colitis) are the most detailed KPV reports. The recurring narrative: reduction in flare frequency and severity within 4–8 weeks, described as a meaningful quality-of-life improvement rather than full remission. Accounts most often frame KPV as adjunctive — used alongside conventional IBD management rather than as a replacement. Oral capsule or suppository routes appear consistently in IBD accounts, with users citing localised delivery as a rationale for route selection. Accounts from users without a formal IBD diagnosis but with chronic gut sensitivity also appear frequently.
What are the reported side effects of KPV?
KPV is among the peptides with the fewest side effect reports in community accounts. The most common adverse effects mentioned: mild injection site reactions when injected (less common than oral use), rare reports of temporary nausea. The absence-of-side-effects framing is notably more common in KPV accounts than with most other compounds — a recurring theme is users describing surprise at tolerating it well after struggling with conventional IBD medications. No serious adverse events appear consistently in community reports at typical doses.
How is KPV typically dosed in community protocols?
Community accounts describe variable dosing depending on route and goal. Injectable accounts typically cite 500mcg–2mg daily. Oral capsule accounts describe higher doses (due to degradation before absorption) in the range of 5–10mg per dose. Suppository accounts for IBD describe doses calibrated for local effect. Most accounts describe a loading period of 4–8 weeks before assessing response. Cycling is less consistently described for KPV than for other peptides — some accounts describe continuous use for chronic conditions without reported tolerance development.
KPV Peptide: Anonymous Reports — Peptide Confessions